Why is Ishita Drugs falling/rising?

As of 26-Jun, Ishita Drugs & Industries Ltd is experiencing a price increase, currently at Rs 84.00, reflecting a rise of 2.7 or 3.32%. The stock opened with a gain of 4.51% today and reached an intraday high of Rs 84.97. It has outperformed its sector by 3.24% and is trading above all its moving averages, indicating strong momentum. Over the past week, the stock has shown a return of 14.91%, significantly higher than the Sensex's 2.94%. Despite a year-to-date decline of 9.12%, the stock has generated a notable 29.23% return over the past year, which is substantially better than the market's average return of 4.11%. The company has an attractive valuation with a Price to Book Value of 2.5, and its rising investor participation, evidenced by a 708.25% increase in delivery volume, further supports the stock's upward movement.
In the broader market context, Ishita Drugs' recent performance stands out, particularly in the short term, where it has significantly outpaced the benchmark returns. The stock's strong performance can be attributed to its attractive valuation and positive returns over the past year, despite some concerns regarding its long-term fundamental strength, such as a relatively low Return on Equity (ROE) of 8.34% and weak growth in net sales. While the company has shown a solid return in the last year, the flat results reported in March 2025 and the weak EBIT to Interest ratio indicate potential risks that investors should consider. Overall, the combination of strong short-term performance and attractive valuation metrics has contributed to the stock's rising price.